TOMPKINS FINANCIAL CORP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
TOMPKINS FINANCIAL CORP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2022$37,000
+5.7%
5600.0%0.01%
+20.0%
Q1 2022$35,000
+16.7%
5600.0%0.01%0.0%
Q4 2021$30,000
-25.0%
5600.0%0.01%
-28.6%
Q3 2021$40,000
-35.5%
5600.0%0.01%
-30.0%
Q1 2021$62,000
-7.5%
5600.0%0.01%
-16.7%
Q4 2020$67,000
+36.7%
5600.0%0.01%
+33.3%
Q3 2020$49,000
-2.0%
5600.0%0.01%
-18.2%
Q2 2020$50,0005600.01%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders